Cargando…

A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of Mice

Gene therapy for the treatment of genetic disorders has demonstrated considerable therapeutic success in clinical trials. Among the most effective and commonly used gene delivery vectors are those based on adeno-associated virus (AAV). Despite these advances in clinical gene therapy, further improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Lieshout, Laura P., Domm, Jakob M., Rindler, Tara N., Frost, Kathy L., Sorensen, Debra L., Medina, Sarah J., Booth, Stephanie A., Bridges, James P., Wootton, Sarah K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054702/ https://www.ncbi.nlm.nih.gov/pubmed/30038936 http://dx.doi.org/10.1016/j.omtm.2018.04.005

Ejemplares similares

Engineered AAV8 capsid acquires heparin and AVB sepharose binding capacity but has altered in vivo transduction efficiency
por: van Lieshout, Laura P., et al.
Publicado: (2023)

AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge
por: van Lieshout, Laura P., et al.
Publicado: (2022)

A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency
por: Kang, Martin H., et al.
Publicado: (2020)

Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the Brain
por: Depla, Josse A., et al.
Publicado: (2020)

Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS
por: Stanton, Alexandra C., et al.
Publicado: (2023)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

Macrophage Depletion via Clodronate Pretreatment Reduces Transgene Expression from AAV Vectors In Vivo
por: Yu, Darrick L., et al.
Publicado: (2021)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Tailoring the AAV2 capsid vector for bone-targeting
por: Alméciga-Díaz, Carlos J., et al.
Publicado: (2018)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

The hunt for novel AAV capsids with improved cardiac tropism
por: Miguel-dos-Santos, Rodrigo, et al.
Publicado: (2023)

AAV vector distribution in the mouse respiratory tract following four different methods of administration
por: Santry, Lisa A., et al.
Publicado: (2017)

Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo
por: Michelfelder, Stefan, et al.
Publicado: (2011)

JSRV Intragenic Enhancer Element Increases Expression from a Heterologous Promoter and Promotes High Level AAV-Mediated Transgene Expression in the Lung and Liver of Mice
por: Yu, Darrick L., et al.
Publicado: (2020)

Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
por: Kanaan, Nicholas M., et al.
Publicado: (2017)

Site-Specific N-Glycosylation on the AAV8 Capsid Protein
por: Aloor, Arya, et al.
Publicado: (2018)

Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries
por: Schmit, Pauline F., et al.
Publicado: (2019)

AAV- based vector improvements unrelated to capsid protein modification
por: Shitik, Ekaterina M., et al.
Publicado: (2023)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production
por: Halbert, Christine L., et al.
Publicado: (2010)

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021)

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
por: Ivanchenko, Maryna V., et al.
Publicado: (2021)

Microglia-specific targeting by novel capsid-modified AAV6 vectors
por: Rosario, Awilda M, et al.
Publicado: (2016)

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid
por: Zinn, Eric, et al.
Publicado: (2022)

The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease
por: Majer, Anna, et al.
Publicado: (2019)

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
por: Gonzalez-Sandoval, Adriana, et al.
Publicado: (2023)

The U3 and Env Proteins of Jaagsiekte Sheep Retrovirus and Enzootic Nasal Tumor Virus Both Contribute to Tissue Tropism
por: Rosales Gerpe, María C., et al.
Publicado: (2019)

Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
por: Chakrabarty, Paramita, et al.
Publicado: (2013)

Structural basis of receptor usage by the engineered capsid AAV-PHP.eB
por: Jang, Seongmin, et al.
Publicado: (2022)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
por: Markusic, David M., et al.
Publicado: (2017)

Early Mechanisms of Pathobiology Are Revealed by Transcriptional Temporal Dynamics in Hippocampal CA1 Neurons of Prion Infected Mice
por: Majer, Anna, et al.
Publicado: (2012)

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011)

Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
por: Tan, Yong Zi, et al.
Publicado: (2018)

Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
por: Weinmann, Jonas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a3i0kqudmqrdsctk3o86atk4lt